It is undeniable that Covid-19 has had a tremendous impact on private equity activity in Europe and North America. Following the initial focus on stabilising their portfolios, investors are now focusing on strengthening and positioning them for future growth in a market where customers are changing their behaviors in irreversible ways.
Pre-Covid, commercial excellence was already emerging as a new imperative for portfolio companies and a growing part of our private equity clients’ value creation playbooks. Despite the fact that only 45% of private equity investors realised deal value through revenue enhancement in 2019, it is clear that improving your portfolio companies’ commercial capabilities raises the odds of organic growth, something which has become an essential component of deal success.
The go-to-market and leadership capabilities required to respond effectively post-Covid and enable future growth are now more important than ever before, and will be the focus of our panel discussion:
Strategic and tactical changes within B2B and B2C portfolio companies - learnings from Q2/Q3
The role of digital marketing in B2B companies as a driver for organic growth
Leadership challenges and skillsets required post-Covid
The role of operating partners in driving commercial excellence across a portfolio